Guide

What happens if you grant options without a 409A valuation

Updated

This matters because of who pays. It is not the company that skipped the valuation but the employee holding the options, often on stock they cannot sell.

Talk to a specialist

Question 1

What are you granting?

Section 409A bites on stock rights whose exercise price is below the fair market value of the underlying stock on the grant date. Not every equity award raises the question.

What the statute does

Under 26 U.S.C. 409A(a)(1), a nonqualified deferred compensation plan can fail the requirements. Then all compensation deferred under it for the taxable year and all preceding taxable years is includible in gross income. That applies to the extent it is not subject to a substantial risk of forfeiture.

The tax is then increased by two things. One is interest at the underpayment rate plus one percentage point. The other is an amount equal to 20 percent of the compensation required to be included in gross income.

409A and stock options: how an option becomes deferred compensation

A stock option with an exercise price at or above the underlying stock's fair market value on the grant date is generally not deferred compensation here. Granted below that value, it can be.

That is the whole mechanism, and it explains why the valuation is the control. The valuation does not create the protection by existing; it creates it by establishing, inside a presumption, what fair market value was on the day of the grant.

Why it surfaces in diligence

Because a buyer's counsel asks for the cap table, the option grants, the board approvals and the valuations, and lines them up against each other. It is one of the first things checked and one of the easiest to check.

Discovering it then is the expensive version. It arrives at the other side's point of maximum leverage and affects employees about to have a good day. People who did not create the problem fix it under time pressure.

The two things to do today

Stop granting until a valuation is in place. Continuing to grant while the position is being investigated adds to the exposure at the rate of one grant per hire.

Assemble the record: every grant date, every board approval or written consent, every exercise price, and the valuation relied on for each. That document is the first thing any adviser will ask for, and building it is work you would have to do anyway.

Want quotes from 409A providers?

Tell us the stage of the company and when you need the report. Valuation providers who work with companies at that stage will contact you directly.

Next: where to reach you.

  • Free, no obligation
  • Matched on stage and timing, not on who pays most
  • No marketing lists, ever

Questions, answered directly

Do all 409A stock options need a valuation?

Any private company option needs a defensible fair market value at grant. One priced at or above it is generally not deferred compensation under section 409A; one below it can be. The valuation shows, inside a safe harbour, what that value was. Without one, the exercise price rests on an assumption the IRS has no reason to presume reasonable.

Sources

This site's own datasets, every figure quoted from its source and dated:

  • The 409A Platform Bundle Coverage carries 2 published figures read from 2 sources' own pages, from 990 to 1,000 USD, read 11 November 2026.
  • The median published figure in the 409A Quote Price Index is 899 USD across 13 figures from 11 sources' own pages (range 499 to 2,000 USD; 12 sources publish a figure, some priced per year), read 11 November 2026.
  • The 409A Safe Harbor and Refresh Rules carries 3 published figures read from 3 sources' own pages, from 30 to 90 day, read 8 November 2026.
  1. 26 CFR 1.409A-1, definitions and covered plans (Cornell LII)
  2. 26 U.S.C. 409A, inclusion in gross income of deferred compensation (Cornell LII)
  3. IRS Notice 2005-1, guidance under section 409A
  4. IRS Internal Revenue Manual 4.48.4, Business Valuation Guidelines
  5. SEC Investment Adviser Public Disclosure

Find out which safe harbour you are in

What you are granting, whether the stock is traded, whether the start-up conditions hold, and who would sign the report.

Talk to a specialist